Independent medical review — the honest odds

When utilization reviewUR Utilization Review. The process that approves, modifies, or denies each treatment request. A modification is a denial of what it left out. modifies, delays, or denies your treatment, California does not send the medical dispute to a judge. It sends it to an independent physician reviewer through an organization under contract to the state — Maximus — who reads the file and decides whether the treatment is medically necessary under the MTUSMTUS Medical Treatment Utilization Schedule. California’s treatment guidelines. Four of them — shoulder, elbow, hand/wrist/forearm and traumatic brain injury — were replaced January 2, 2026..

The reviewer never examines you. The reviewer’s identity is confidential by statute. The decision is binding on all parties, and no judge, no Appeals Board, and no appellate court may substitute a contrary medical-necessity determination. This structure was upheld against constitutional challenge in Stevens v. WCABWCAB Workers’ Compensation Appeals Board. The court system that decides these cases. 23 district offices statewide. (2015) 241 Cal.App.4th 1074, and against a separation-of-powers challenge in Ramirez v. WCAB (2017) 10 Cal.App.5th 205.

From the DWC’s 2026 IMR Report analyzing 2025 data — 266,756 disputed treatment requests.

Two observations worth having. Spinal injections were added to the mandatory prospective-review list effective April 1, 2026 — a category in which the reviewer sustains the denial 93.3% of the time. And rehabilitation and pharmaceuticals together are 53.5% of all disputes, both sitting near a 9% overturn rate. If your denial is for physical therapy or medication, plan accordingly — which usually means putting the effort into the quality of the resubmission and into checking UR timeliness, rather than into the IMR filing alone.

Within pharmaceuticals the spread is wider still. Antidepressants are overturned 24.1% of the time — the best-performing drug class by a distance. Muscle relaxants are overturned 1.4%. Opioids, 6.8%. Topical analgesics, 6.0%. NSAIDs, 18.9%.

85% of 2025 cases were handled by California-licensed reviewers. 77% of decisions came from board-certified specialists in occupational medicine, orthopedic surgery, pain medicine, or physical medicine and rehabilitation.

Occupational medicine physicians decide more than four of every ten California IMRs. Their identities are confidential. Turnaround is fast and the deadlines are met: average 6–7 days from receipt of complete records to determination, and 99.99% of standard cases issued within the 30-day statutory deadline — only 13 cases statewide exceeded it. Whatever criticisms IMR attracts, being slow is not one of them.

You may appeal to the WCAB within 30 days, by verified appeal. The determination is presumed correct and may be set aside only on clear and convincing evidence of one of five grounds: the Administrative Director acted without or in excess of their powers; the determination was procured by fraud; the reviewer had a material conflict of interest violating § 139.5; the determination resulted from bias on the basis of a protected characteristic; or the determination resulted from a plainly erroneous express or implied finding of fact, where the mistake is a matter of ordinary knowledge based on the information submitted — and not a matter subject to expert opinion.

And then the sting. If you win, the dispute is remanded for a second IMR by a different review organization — or a different reviewer at the same one. A successful appeal buys you another IMR. It does not buy you treatment. That is why IMR is, for practical purposes, final.

If the medical question is effectively unappealable, the procedural question is not. Under Dubon II (WCAB en banc, 2014), a UR decision that is untimely is invalid — and when UR is invalid, the medical necessity dispute goes to a workers’ compensation judgeWCJ Workers’ Compensation Judge. Decides your case. There is no jury., not to IMR. Stevens left that intact. Timeliness is a legal question the Board still decides.

Giron v. KDF Forestry (WCAB panel, April 6, 2026) is the live example. RFARFA Request for Authorization. The form your doctor uses to request treatment. received September 4, 2025; decision due September 11. The employer made phone calls to the treating physician and treated the deadline as extended to fourteen days. The panel reversed the judge: phone calls “did not automatically extend the deadline to 14 days under current law,” and there was no written notice of missing information. UR invalid, medical necessity to the Board.

• File the IMR application — always, and on time — It costs nothing and failing to file forfeits the issue.
• Have the UR denial checked for timeliness and procedural defect — This is where cases are actually won.
• Submit your own supporting documents to IMR — You are entitled to, and almost nobody does.
• Work with your treating physician on the resubmission — MTUS cited, guideline variance explained, evidence attached, and a documented material change if the twelve-month rule is in play.

What makes a UR denial invalid

We will not pretend to neutrality: we represent injured workers, and we think a system in which nine of ten denials are upheld by an anonymous reviewer who never examines the patient, with no meaningful appeal on the merits, is difficult to defend as a matter of design. But the honest picture is contested, and you should have it.

The payer side points to a real finding: research by the California Workers’ Compensation Institute has found that in the twelve months ending March 2025, the top 1% of requesting physicians — 81 doctors — generated 42.2% of all disputed service requests, with the top ten alone accounting for 10.9%. Seven of those top ten repeated from the prior year. Their reading is that a small group of outlier prescribers drives the volume, and IMR is doing what it was built to do. CWCI is insurer-funded; we cite it because the finding is real, not because the framing is neutral.

The applicant side reads the same number differently: a small group of physicians still willing to fight for care that most doctors have stopped requesting, because the odds are nine to one against and the paperwork is unpaid.

Both readings fit the data. What is not in dispute is that the overturn rate has moved within a narrow band for a decade, that the reviewers are anonymous, and that winning an appeal gets you a second review rather than a treatment authorization.